From: Persistent inflammation worsens short-term outcomes in massive stroke patients
Beta | SE | Wald | p | OR, 95% CI | |
---|---|---|---|---|---|
Age | 0.014 | 0.023 | 0.359 | 0.549 | 1.01, 0.97–1.06 |
Gender | −0.004 | 0.536 | 0.000 | 0.994 | 0.99, 0.35–2.85 |
NLR rank a | 0.555 | 0.264 | 4.438 | 0.035* | 1.74, 1.01–2.92 |
SBP, mmol/L | 0.003 | 0.015 | 0.042 | 0.837 | 1.00, 0.97–1.03 |
Glc, mmol/L | 0.350 | 0.160 | 4.802 | 0.028* | 1.42, 1.04–1.94 |
Bil, mmol/L | 0.056 | 0.044 | 1.587 | 0.208 | 1.05, 0.97–1.15 |
UTI | 1.389 | 1.222 | 1.293 | 0.256 | 4.01, 0.36–44.01 |
NEU | 0.935 | 0.564 | 2.749 | 0.097 | 2.53, 0.84–7.69 |
Constant | −4.219 | 3.170 | 1.771 | 0.183 | 0.02, − |